logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Colin Hale

liverpool clinical research facility
H指数:17
被引数:1,139

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study

奥普米gia静脉注射给药在住院COVID-19患者中的最佳剂量与安全性：一项剂量递增、随机对照的Ib期研究

CLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
2026-03-180
OAAI
Tim Rowland; Richard FitzGerald; Elizabeth Challenger; Laura Dickinson; Laura J. Else; Lauren Walker; Colin Hale; Victoria Shaw; Callum Kelly; Rebecca Lyon; Jennifer Gibney; Karim Dhamani; Margaret Irwin; Yvanne Enever; Michelle Tetlow; William Wood; Helen Reynolds; Justin Chiong; Orod Osanlou; Henry Pertinez; Katie Bullock; William Greenhalf; Andrew Owen; David G. Lalloo; Michael Jacobs; Julian A. Hiscox; Thomas Jaki; Pavel Mozgunov; Geoffrey Saunders; Gareth Griffiths; Saye H. Khoo; Thomas E. Fletcher; the AGILE CST-6 Study Group
Pharmacokinetics of the inactive favipiravir metabolite, favipiravir hydroxide (M1), as a proxy for establishing metabolic activity in patients receiving intravenous favipiravir for treatment of SARS-CoV-2 infection

非活性法匹拉韦代谢物法匹拉韦氢氧化物（M1）的药代动力学，作为建立接受静脉注射法匹拉韦治疗SARS-CoV-2感染患者代谢活性的替代指标

British Journal of Clinical Pharmacology
IF3
2025-09-030
OAAI
E. Challenger; L. Else; L. Dickinson; T. Rowland; W. Wood; C. Hale; R. Lyon; H. Reynolds; J. Chiong; A. Owen; R. FitzGerald; T. Fletcher; S. Khoo
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
LANCET INFECTIOUS DISEASES
IF31
2023-02-0161
OAAI
Khoo, Saye H.; FitzGerald, Richard; Saunders, Geoffrey; Middleton, Calley; Ahmad, Shazaad; Edwards, Christopher J.; Hadjiyiannakis, Dennis; Walker, Lauren; Lyon, Rebecca; Shaw, Victoria; Mozgunov, Pavel; Periselneris, Jimstan; Woods, Christie; Bullock, Katie; Hale, Colin; Reynolds, Helen; Downs, Nichola; Ewings, Sean; Buadi, Amanda; Cameron, David; Edwards, Thomas; Knox, Emma; Donovan-Banfield, I'ah; Greenhalf, William; Chiong, Justin; Lavelle-Langham, Lara; Jacobs, Michael; Northey, Josh; Painter, Wendy; Holman, Wayne; Lalloo, David G.; Tetlow, Michelle; Hiscox, Julian A.; Jaki, Thomas; Fletcher, Thomas; Griffiths, Gareth
Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial
NATURE COMMUNICATIONS
IF15.7
2022-11-2625
OAAI
Donovan-Banfield, I'ah; Penrice-Randal, Rebekah; Goldswain, Hannah; Rzeszutek, Aleksandra M.; Pilgrim, Jack; Bullock, Katie; Saunders, Geoffrey; Northey, Josh; Dong, Xiaofeng; Ryan, Yan; Reynolds, Helen; Tetlow, Michelle; Walker, Lauren E.; FitzGerald, Richard; Hale, Colin; Lyon, Rebecca; Woods, Christie; Ahmad, Shazaad; Hadjiyiannakis, Dennis; Periselneris, Jimstan; Knox, Emma; Middleton, Calley; Lavelle-Langham, Lara; Shaw, Victoria; Greenhalf, William; Edwards, Thomas; Lalloo, David G.; Edwards, Christopher J.; Darby, Alistair C.; Carroll, Miles W.; Griffiths, Gareth; Khoo, Saye H.; Hiscox, Julian A.; Fletcher, Thomas
Pharmacokinetics of ss-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
CLINICAL INFECTIOUS DISEASES
IF7.3
2022-03-1015
OAAI
FitzGerald, Richard; Dickinson, Laura; Else, Laura; Fletcher, Thomas; Hale, Colin; Amara, Alieu; Walker, Lauren; Penchala, Sujan Dilly; Lyon, Rebecca; Shaw, Victoria; Greenhalf, William; Bullock, Katie; Lavelle-Langham, Lara; Reynolds, Helen; Painter, Wendy; Holman, Wayne; Ewings, Sean; Griffiths, Gareth; Khoo, Saye
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2
CLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
2021-11-1314
OAAI
Walker, Lauren E.; FitzGerald, Richard; Saunders, Geoffrey; Lyon, Rebecca; Fisher, Michael; Martin, Karen; Eberhart, Izabela; Woods, Christie; Ewings, Sean; Hale, Colin; Rajoli, Rajith K. R.; Else, Laura; Dilly-Penchala, Sujan; Amara, Alieu; Lalloo, David G.; Jacobs, Michael; Pertinez, Henry; Hatchard, Parys; Waugh, Robert; Lawrence, Megan; Johnson, Lucy; Fines, Keira; Reynolds, Helen; Rowland, Timothy; Crook, Rebecca; Okenyi, Emmanuel; Byrne, Kelly; Mozgunov, Pavel; Jaki, Thomas; Khoo, Saye; Owen, Andrew; Griffiths, Gareth; Fletcher, Thomas E.
The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite β-d-N4-hydroxycytidine in human plasma and saliva

用于同时定量人血浆和唾液中莫那比拉韦及其代谢物 β-d-n4-羟基胞苷的新型lc-ms/MS方法的开发和验证

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
IF3.1
2021-11-0153
OAAI
Amara, Alieu; Penchala, Sujan Dilly; Else, Laura; Hale, Colin; FitzGerald, Richard; Walker, Lauren; Lyons, Rebecca; Fletcher, Tom; Khoo, Saye
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
IF3.6
2021-08-2783
OAAI
Khoo, Saye H.; Fitzgerald, Richard; Fletcher, Thomas; Ewings, Sean; Jaki, Thomas; Lyon, Rebecca; Downs, Nichola; Walker, Lauren; Tansley-Hancock, Olana; Greenhalf, William; Woods, Christie; Reynolds, Helen; Marwood, Ellice; Mozgunov, Pavel; Adams, Emily; Bullock, Katie; Holman, Wayne; Bula, Marcin D.; Gibney, Jennifer L.; Saunders, Geoffrey; Corkhill, Andrea; Hale, Colin; Thorne, Kerensa; Chiong, Justin; Condie, Susannah; Pertinez, Henry; Painter, Wendy; Wrixon, Emma; Johnson, Lucy; Yeats, Sara; Mallard, Kim; Radford, Mike; Fines, Keira; Shaw, Victoria; Owen, Andrew; Lalloo, David G.; Jacobs, Michael; Griffiths, Gareth

研究方向

暂未获取到该数据
H
Helen Reynolds
H 指数:23论文数:88被引数:2,634
S
Saye Khoo
H 指数:72论文数:544被引数:2.2万
R
Richard J. Fitzgerald
H 指数:83论文数:618被引数:2.2万
L
Lauren Walker
H 指数:20论文数:92被引数:1,903
R
Rebecca Lyon
H 指数:12论文数:38被引数:599
J
Justin Chiong
H 指数:12论文数:37被引数:568
G
Gareth Griffiths
H 指数:68论文数:542被引数:2.1万
L
Laura Else
H 指数:29论文数:188被引数:2,484
D
David G. Lalloo
H 指数:69论文数:460被引数:2.0万
T
Tom Fletcher
H 指数:47论文数:241被引数:1.2万